Ignite Creation Date:
2025-12-25 @ 5:07 AM
Ignite Modification Date:
2025-12-26 @ 4:11 AM
Study NCT ID:
NCT06952127
Status:
COMPLETED
Last Update Posted:
2025-04-30
First Post:
2025-04-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).
Sponsor:
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
Organization:
Study Overview
Official Title:
Pilot Study Evaluating the Feasibility and Appropriateness of a Telerehabilitation Exercise Program in People With Post-COVID-19 Sequelae: a Single-center Randomized Trial.
Status:
COMPLETED
Status Verified Date:
2025-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TEPCO
Brief Summary:
The goal of this study pilot randomized controlled study is to evaluate the feasibility of the study procedures and to compare the preliminary efficacy of a rehabilitation program given in a "remote" (telerehabilitation) or "face-to-face" model for adult patients who had confirmed SARS-CoV-2 infection and still have symptoms after eight weeks of infection. The main question it aims to answer is:
* Are the study procedures feasible?
* Will the two groups have similar results for the preliminary efficacy outcomes?
Researchers will compare group telerehabilitation to a face-to-face group to see if it's comparable.
Participants will:
* Take part in a 60-minute training session, 3 times a week in person or remotely
* Visit the clinic before starting the training program and after 8 weeks of training
* Keep a diary of their symptoms, if any
* Are the study procedures feasible?
* Will the two groups have similar results for the preliminary efficacy outcomes?
Researchers will compare group telerehabilitation to a face-to-face group to see if it's comparable.
Participants will:
* Take part in a 60-minute training session, 3 times a week in person or remotely
* Visit the clinic before starting the training program and after 8 weeks of training
* Keep a diary of their symptoms, if any
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 889 | REGISTRY | Base de données des projets de recherche du CIUSSS-MCQ | View |